Clinical Trial Update: Safety and Efficacy of Pioglitazone as an Anti-inflammatory for the Treatment of Cystic Fibrosis (CF) Lung Disease [NA]

View source ↗

Summary

This clinical trial update evaluates pioglitazone as an anti-inflammatory treatment for cystic fibrosis lung disease. The trial is completed and results were po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Actos (pioglitazone) (pioglitazone)

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Cystic Fibrosis | NA | Status: COMPLETED | Results posted: 2018-02-23